A Pharmacist's Query Avoiding Exacerbation of Adverse Effects in a Patient with Acyclovir Encephalopathy: A Case Report
We report a haemodialysis patient with end-stage renal failure whom a pharmacist aided in the management of acyclovir (ACV) encephalopathy, which may have been related to valacyclovir hydrochloride (VACV) administered without sufficient dose reduction. The patient 78 years was admitted with a tentat...
Saved in:
Published in | YAKUGAKU ZASSHI Vol. 142; no. 7; pp. 771 - 774 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
公益社団法人 日本薬学会
01.07.2022
Pharmaceutical Society of Japan |
Subjects | |
Online Access | Get full text |
ISSN | 0031-6903 1347-5231 1347-5231 |
DOI | 10.1248/yakushi.21-00237 |
Cover
Summary: | We report a haemodialysis patient with end-stage renal failure whom a pharmacist aided in the management of acyclovir (ACV) encephalopathy, which may have been related to valacyclovir hydrochloride (VACV) administered without sufficient dose reduction. The patient 78 years was admitted with a tentative diagnosis of varicella zoster viral meningitis. A pharmacist suspected ACV encephalopathy related to excessive VACV administration and raised a query with the attending physician. According to the pharmacist's proposal, ACV administration was discontinued and continuous hemodiafiltration (CHDF) was performed. On day 5 of hospitalisation, the consciousness disorder was improved. In this report, we showed the detailed CHDF conditions of the present case, and the contribution of a pharmacist to treating and avoiding ACV encephalopathy was discussed. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0031-6903 1347-5231 1347-5231 |
DOI: | 10.1248/yakushi.21-00237 |